• ICG001: Precision Wnt/β-Catenin Inhibition for Advanced Dise

  2026-06-11

  Explore ICG001, a potent Wnt/β-catenin pathway inhibitor, and discover its unique selectivity for CBP/β-catenin interactions in cancer, fibrosis, and regenerative research. This article delivers new insights into targeted assay design and translational applications.

• Protease Inhibitor Cocktail: EDTA-Free Strategies for Protei

  2026-06-11

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) from APExBIO revolutionizes protein extraction in high-stakes applications such as OXPHOS-targeted cancer research and kinase assays. Its EDTA-free, broad-spectrum formulation offers unmatched compatibility and reproducibility, ensuring maximal protein integrity where it matters most.

• HSBP7 Loss Restores Function in Titin Cardiomyopathy Models

  2026-06-10

  Chopra et al. introduce CARDIO, a high-content imaging assay, to systematically profile morphological and functional alterations in human cardiomyocytes derived from induced pluripotent stem cells (iPS-CMs). Their study identifies HSPB7 loss as a novel modifier that reverses contractile dysfunction in titin-deficient dilated cardiomyopathy, offering new mechanistic insights for heart failure research.

• MMP7 Drives EMT and Liver Fibrosis via E-cadherin/β-Catenin

  2026-06-10

  This study elucidates how matrix metalloproteinase 7 (MMP7) promotes liver fibrosis in biliary atresia by inducing epithelial–mesenchymal transition (EMT) through E-cadherin cleavage and β-catenin signaling. The findings pinpoint MMP7 as a mechanistic driver of fibrosis and a promising therapeutic target, advancing understanding of fibrogenic pathways in pediatric liver disease.

• Anlotinib Hydrochloride: Multi-Target Tyrosine Kinase Inhibi

  2026-06-09

  Anlotinib hydrochloride empowers cancer research by enabling highly selective, quantitative inhibition of angiogenesis and tumor proliferation pathways. Its unique multi-target kinetic profile, robust pharmacodynamics, and superior in vitro safety position it as a next-generation standard for endothelial migration and tube formation assays.

• Luminescent ATP Detection Assay Kit: Precision in Cellular A

  2026-06-09

  The Luminescent ATP Detection Assay Kit leverages robust firefly luciferase chemistry to deliver highly sensitive, reproducible ATP quantification across cells and tissues. Its streamlined protocol and compatibility with downstream applications set a new standard for energy metabolism and inflammation research.

• Gly-Gly-Phe-Gly: Advancing Bioconjugation and ADC Precision

  2026-06-08

  Harnessing the flexible linker properties of the GGFG peptide, researchers can streamline drug conjugation and antibody-drug conjugate workflows with unmatched reproducibility. This guide details protocol parameters, advanced applications, and actionable troubleshooting tips that leverage high-purity Gly-Gly-Phe-Gly from APExBIO for next-generation peptide engineering.

• HyperScript™ Reverse Transcriptase: Precision cDNA Synthesis

  2026-06-08

  HyperScript™ Reverse Transcriptase from APExBIO elevates cDNA synthesis workflows, excelling where structured or low-abundance RNA challenge conventional enzymes. Its advanced thermal stability and reduced RNase H activity drive superior results in high-demand applications such as qPCR and transcriptomic profiling.

• Silymarin: Milk Thistle Extract for Advanced Bench Research

  2026-06-07

  Silymarin, a milk thistle extract, offers unparalleled versatility for oxidative stress, cancer, and antiviral research, thanks to its well-characterized chemistry and robust protocol flexibility. This guide translates cutting-edge findings and expert workflow tips into actionable protocols, with troubleshooting strategies designed for reproducibility and reliable results.

• EZ Cap™ Mouse IL-12 mRNA (m1Ψ): Precision Immune Modulation

  2026-06-06

  Explore how EZ Cap™ Mouse IL-12 mRNA (m1Ψ) enables highly targeted immune modulation through advanced mRNA engineering. This article provides new insights into delivery strategies and translational assay design, with a focus on actionable guidance for immunotherapy research.

• Glioma Cells Drive Soluble PD-L1 via Wnt/β-catenin to Suppre

  2026-06-05

  This study demonstrates that glioma cells generate soluble PD-L1 (sPD-L1) by activating the Wnt/β-catenin pathway, which impairs CD8+ T cell function and correlates with tumor aggressiveness and poor survival. These findings highlight sPD-L1 as both a prognostic biomarker and potential therapeutic target in glioma, with direct implications for optimizing immunotherapy strategies.

• ATRNL1 Identified as a Key Regulator in Human Atrial Fibrill

  2026-06-05

  This study delivers the first large-scale, single-nucleus transcriptomic analysis of human atrial fibrillation (AF), revealing ATRNL1 as a crucial regulator in cardiomyocyte stress response and conduction. The findings provide a new molecular target for AF research and highlight the value of single-nucleus RNA sequencing for dissecting cell-type specific disease mechanisms.

• Proteinase K: Broad-Spectrum Serine Protease for DNA Purity

  2026-06-04

  Unlock high-fidelity DNA workflows with recombinant Proteinase K, the industry benchmark for contaminant removal and DNA integrity preservation. See how APExBIO’s enzyme streamlines complex sample prep, enables robust fungal vesicle research, and delivers reproducible results even under challenging conditions.

• D-Luciferin: Precision Firefly Luciferase Substrate for Biol

  2026-06-04

  D-Luciferin enables ultrasensitive bioluminescence workflows for real-time tumor burden assessment and gene expression monitoring. This article delivers actionable optimization strategies and protocol guidance, leveraging lessons from recent immunotherapy advances and APExBIO’s high-purity substrate.

• Tumor-Specific Genetic Engineering Enhances T Cell Immunity

  2026-06-03

  He et al. (2025) introduce a tumor-targeted plasmid, P αCD3&LIGHT, which synergistically drives T cell infiltration and activation in 'immune-cold' solid tumors. This strategy significantly augments the efficacy of immune checkpoint inhibitors and CAR-T therapies, with broad translational implications for solid tumor immunotherapy.

16398 records 1/1094 page Next 12345 下5页 Last page